CA125 + HE4 Study Publications and Animation
Download the full study results and a clinical slide set
Thank you for viewing our animation on CA125 + HE4, the new ovarian cancer risk stratification test. Now, you can view and download the full study publications below, as well as a clinical slide set with additional information.
- View the 2007 pilot study
that identified HE4 as the best single biomarker for ovarian cancer detection when combined with CA125. - View the 2008 multicentre study
that successfully classified women into high and low risk groups using the dual marker combination of CA125 and HE4. - View a clinical slide set on CA125 + HE4
Sign Up for Updates
- Sign up to receive more information in the future